Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Two strengths of ranitidine among further February price concessions

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following 14 items for February 2020 prescriptions.

An initial 13 price concessions were announced on February 19. Among the latest concessionary prices are two strengths of the anti-acid ranitidine

Drug
Strength
Form
Price
Amiodarone
200mg
tablets (28)
£2.55
Desmopressin
200microgram
tablets (30)
£19.47
Lymecycline
408mg
capsules (28)
£6.50
Meloxicam
7.5mg
tablets (30)
£3.25
Mirtazapine
15mg
tablets (28)
£2.20
Mirtazapine
30mg
tablets (28)
£2.20
Mirtazapine
45mg
tablets (28)
£2.52
Pizotifen
1.5mg
tablets (28)
£5.75
Ranitidine
150mg
tablets (60)
£6.80
Ranitidine
300mg
tablets (30)
£6.14
Tolterodine
2mg
tablets (56)
£4.58
Trihexyphenidyl
2mg
tablets (84)
£7.50
Venlafaxine
37.5mg
tablets (56)
£6.94
Venlafaxine
75mg
tablets (56)
£14.20

Do these reflect the prices you have paid in February so far?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006344

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel